v3.26.1
6. INCOME TAXES
12 Months Ended
Mar. 31, 2026
INCOME TAXES  
NOTE 6 - INCOME TAXES

NOTE 6—INCOME TAXES

Loss before income taxes and the provision for income taxes consists of the following:

Year Ended March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2024

 

(In thousands)

Loss before income taxes:

U.S.

$

(6,940)

$

(4,511)

$

(12,414)

Foreign

(6,438)

(5,998)

(7,603)

$

(13,378)

$

(10,509)

$

(20,017)

Current income tax expense:

U.S. federal

$

$

$

State

2

2

1

Foreign

193

126

67

195

128

68

Deferred income tax expense (benefit):

U.S. federal

2

2

2

State

(329)

Foreign

(327)

2

2

Provision (benefit) for income taxes

$

(132)

$

130

$

70

The provision for income tax differs from the amount of income tax determined by applying the applicable U.S. statutory income tax rate to pre-tax loss as follows:

Year Ended March 31, 2026

(in thousands)

Percent

U.S. Federal taxes at statutory rate

$

(2,808)

21.0

%

State taxes, net of federal benefit

2

0.0

%

Foreign tax effects

Israel - foreign tax rate differential between Israel and the US

(325)

2.4

%

Israel - other

35

(0.3)

%

Cayman Islands - foreign tax rate differential between Cayman Islands and the US

1,593

(11.9)

%

Other foreign jurisdictions

(89)

0.7

%

Research and development tax credits

(318)

2.4

%

Change in valuation allowance

2,536

(19.0)

%

Nontaxable or non-deductible items

Net gain on warrants

(710)

5.3

%

Other

(48)

0.4

%

Benefit for income taxes

$

(132)

1.0

%

Texas makes up the majority of state tax expense.

Year Ended March 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

 

(In thousands)

U.S. Federal taxes at statutory rate

$

(2,203)

$

(4,204)

State taxes, net of federal benefit

2

1

Stock-based compensation

566

408

Tax credits

(404)

(530)

Foreign tax rate differential

1,382

1,663

GILTI tax

232

Lapses of applicable statute of limitations

(767)

Non-deductible expenses and other

1

2

(1,423)

(2,428)

Valuation allowance

1,553

2,498

$

130

$

70

Deferred tax assets and deferred tax liabilities consist of the following:

March 31, 

  ​ ​ ​ ​ ​ ​ ​

2026

  ​ ​ ​

2025

(In thousands)

Deferred tax assets:

Tax credits

$

10,820

$

10,242

Net operating losses

7,369

5,933

Capitalized research and development

4,222

4,429

Stock-based compensation

1,189

1,187

Property and equipment

979

209

Operating lease liabilities

1,688

2,103

Other loss carryover

329

Other reserves and accruals

739

753

Total deferred tax assets

27,335

24,856

Less valuation allowance

(25,384)

(22,794)

Deferred tax assets, net

1,951

2,062

Deferred tax liabilities:

Right of use assets

(1,640)

(2,078)

Total deferred tax liabilities

(1,640)

(2,078)

Net deferred tax asset (liability)

$

311

$

(16)

The cash paid for income taxes, net of refunds, during the year was as follows:

Fiscal year ended March 31, 2026

(In thousands)

Federal

$

(5)

State

2

Foreign

Israel

159

Taiwan

47

$

203

The Company currently intends to indefinitely reinvest earnings in operations outside the United States. No provision has been made for state income taxes that might be payable upon remittance of such earnings, nor is it practicable to determine the amount of such potential liability.

As of March 31, 2026 and 2025, $3.5 million and $3.4 million, respectively, of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets. It is possible, however, that due to lapses of applicable statutes of limitations, that some months or years may elapse before an uncertain position for which the Company has established a reserve is resolved. A reconciliation of unrecognized tax benefits is as follows:

Year Ended March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2024

 

(In thousands)

Unrecognized tax benefits, beginning of period

$

3,356

$

3,948

$

3,723

Lapses of applicable statute of limitations

(767)

Additions based on tax positions related to current year

149

175

225

Unrecognized tax benefits, end of period

$

3,505

$

3,356

$

3,948

There is no unrecognized tax benefit balance as of March 31, 2026 that would affect the Company’s effective tax rate if recognized after considering the valuation allowance. There was no net income tax effect related to Global intangible low-taxed income (“GILTI”) in the Company’s fiscal year ended March 31, 2026.

The Company's federal and state net operating loss carryforwards for income tax purposes are approximately $27.8 million and $26.8 million, respectively, at March 31, 2026. The Company's federal net operating loss carryforwards do not expire and the Company’s state tax net operating loss carryforwards expire beginning in 2034. The Company's federal and state tax credit carryforwards for income tax purposes are approximately $5.9 million and $6.2 million respectively, at March 31, 2026. The Company's federal tax credit carryforwards expire beginning in 2033. The Company's state tax credit carryforwards have no expiration date. Utilization of the Company’s net operating loss carryforwards and research tax credit carryforwards may be subject to substantial annual limitations due to the ownership change limitations provided by the Internal Revenue Code and similar state provisions. The annual limitation could result in the expiration of the net operating loss carryforwards and research tax credit carryforwards before utilization. The Company has not performed an analysis to determine if a limitation applies and whether the limitation would cause the net operating losses to expire unutilized.

Due to historical losses in the U.S., the Company has a full valuation allowance on its U.S. federal and state deferred tax assets. As of March 31, 2026 and 2025, the Company’s gross deferred tax assets of $25.7 million and $22.8 million, respectively, were subject to a valuation allowance of $25.4 million and $22.8 million, respectively. The net valuation allowance increased by $2.6 million in fiscal 2026 and 2025. As of March 31, 2026 and 2025, the Company’s net deferred tax assets or (liabilities) were $311,000 and ($16,000), respectively. The deferred tax assets consist primarily of the tax credits and federal and state net operating losses. Realization of deferred tax assets is dependent upon future taxable income, if any, the amount and timing of which are uncertain. In assessing the realizability of certain deferred tax assets, management determined that it is more likely than not that the majority of its deferred tax assets will not be realized. Therefore, the Company has provided a valuation allowance against these deferred tax assets.

The Company is subject to taxation in the United States and various state and foreign jurisdictions. Fiscal years 2013 through 2025 remain open to examination by the federal tax authorities and fiscal years 2011 through 2024 remain open to examination by the state of California. Fiscal years 2020 through 2025 are generally subject to audit by foreign tax authorities.